Drugs / Endothelin-3
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT01100736 | Jan → Sep 2009 | isoproterenol-mediated vasodilatation, pulmonary arterial hypertension | University of Edinburgh | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Endothelin-3 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01100736 ↗ |
| Action | Activate | “ETB selective agonist (ET-3)” NCT01100736 ↗ |
| Modality | Protein / enzyme biologic | — CHEMBL1790180 ↗ |
| Route | Other | “5 minute local intra-arterial infusion of endothelin-3 at a rate of rate of 60 pmol/min, during forearm blood flow studies” NCT01100736 ↗ |